Last reviewed · How we verify
NCT04904263: ABCIP
Advisory Board on Cancer, Infertility and Pregnancy
trial in Cancer in Pregnancy in 100 participants. Status unknown.
22 May 2024
Quick facts
| Lead sponsor | University Hospital, Gasthuisberg |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 22 May 2021 |
| Primary completion | 22 May 2024 |
| Estimated completion | 22 May 2024 |
| Sites | 1 location across Belgium |
Conditions studied
- Cancer in Pregnancy — all drugs for Cancer in Pregnancy →
- Fertility Preservation — all drugs for Fertility Preservation →
- Cancer — all drugs for Cancer →
- Pregnancy — all drugs for Pregnancy →
Sponsor
University Hospital, Gasthuisberg
Who can join
Eligibility, female only, with Cancer in Pregnancy or Fertility Preservation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Advisory Board on Cancer, Infertility and Pregnancy provides a platform where physicians from all over the world can request recommendations regarding the medical care of pregnant women diagnosed with cancer or regarding fertility preservation. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards. To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04904263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Gasthuisberg trials
Trials by the same sponsor.
- NCT06354738 — Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment · NA · recruiting
- NCT04125446 — Genomic and Epigenomic Alterations After Cancer Treatment in Pregnancy · unknown
- NCT03676478 — Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04904263 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Gasthuisberg
- Last refreshed: 27 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing